200 filings
Page 3 of 10
8-K
j6d9uxc2yc 527jn
14 Aug 18
Sophiris Bio Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights
12:00am
CT ORDER
vortsoe7 6ch31yie
3 Aug 18
Confidential treatment order
11:21am
8-K
si5m634e
28 Jun 18
Submission of Matters to a Vote of Security Holders
4:31pm
8-K
p4qdwyx
25 Jun 18
Sophiris Bio Reports Top-Line Interim Safety and Biopsy Findings For its Phase 2b Clinical Trial of Topsalysin in Localized Prostate Cancer
9:00am
8-K
k1o813sglqb8sn
14 May 18
Sophiris Bio Reports First Quarter 2018 Financial Results and Key Corporate Highlights
4:05pm
DEFA14A
kxh27hglo8
27 Apr 18
Additional proxy soliciting materials
4:06pm
8-K
ayy5a1 8kxg8ugo8mpso
21 Mar 18
Sophiris Bio Reports Fourth Quarter and Full Year 2017 Financial Results and Key Corporate Highlights
12:00am
CT ORDER
q794qgcqenxtk
15 Dec 17
Confidential treatment order
12:00am
8-K
eljt3g39ec
8 Dec 17
Departure of Directors or Certain Officers
12:00am
8-K
l8uvyj 83
9 Nov 17
Sophiris Bio Reports Third Quarter Financial Results and Key Corporate Highlights
12:00am
8-K
u9p9ybp
13 Sep 17
Entry into a Material Definitive Agreement
12:00am
EFFECT
1zoe4olaq ml85wa6s8
30 Aug 17
Notice of effectiveness
12:00am
CORRESP
4nugyn224mdekj9s
28 Aug 17
Correspondence with SEC
12:00am